As more gene therapies come to market, payers need expanded options to protect their plans

August 28, 24

Gene therapies, today and tomorrow

By supporting and encouraging evidence-based access to gene therapy, payers and other segments of U.S. society will be positioned to benefit from future advancements and biopharmaceutical breakthrough...

April 12, 24

The future of gene therapy

Recent research suggests that the number of gene therapies on the market is likely to increase to over 60 by 2030. As rapid advancements in the field continue, here is what plan sponsors can expect to...

Mary Dorholt, PharmD, October 20, 23

Pharmacy in Focus

See the future taking shape in pharmacy and how you can capitalize and prepare for 2024 and beyond.

October 09, 23

Gene therapies: Million-dollar miracles

Gene therapies bring much-needed hope for treating rare conditions, but also concerns, especially around affordability. Learn about strategies plan sponsors can take to address these million-dollar me...

August 31, 23

The importance of utilization management within the medical benefit

The ever-evolving complexity of medications billed through the medical benefit requires continuous investment in processes to manage their increasingly high price tag.

Mark Wong, PharmD, BCACP, August 17, 23